All Type of News
LG Life Sciences won EPO patent for its SR-hGH formulation technology
LG Life Sciences said on December 17 that it won a European Patent Office (EPO) for a novel formulation technology applied to a sustained-release human growth hormone (SR-hGH).
The company noted it filed the patent...
Foreign drug corporations in assorted year-end fest.
At the year end season there appears with a mingled "joy and sorrow" mood among the foreign multinational drug corporations in Korea. Some companies fully kept their normal works until the end of the year regardless o...
Green Cross to construct vaccine plant in Vietnam.
Green Cross signed an agreement with Vietnamese National Institute of Health for a turn-key based construction project of the vaccine plant in association with Samsung Moolsan in the amount of U$28 million on Dec. 17...
KFDA to enforce GLP from next year.
Effective from Jan. 1, 2003 the KGLP will be enforced to apply all pharmaceutical non-clinical tests, and therefore the drug industry has to build up the GLP (Good Laboratory Practice) infra and its activities.
To ...
Restructuring of foreign-invested pharmaceutical firms eyed
Influenced by the overall business setbacks in the domestic pharmaceutical sector due to debt-ridden finance of the National Health Insurance Corporation and other unfavorable factor in next year, foreign-invested pha...
KISTEP earmarks 2003 BT budget at 496.2 billion won
Korea's R&D budge is expected to further grow in parallel with the government's intensive policies to foster new promising technologies in the related fields, a government agency said.
The Korea Institute of Scienc...
Lending acts on license for dispensing oriental drugs are illegal
A pharmacist, who lend his license for dispensing oriental drugs to the others in the absence of pharmacy, should be subject to administrative disposition due to the fact that such lending is regarded as the lending o...
Administrative disposition on Papalazzi-related pharmacies will be decided in early next week
Business sources say that a number of pharmacies are being damaged by Papalazzi who set their eye on some reward by reporting the cases of violating the current SDP function, such as the selling of prescription drugs ...
Drastically simplifying requirements for modified new drugs to register.
The KFDA will drastically simplify the required safety and efficacy data for modified new drugs to register in order to entice its development as following plans.
For the modified new drug only to register its addi...
Korea's PPIs market getting heated
The domestic market scale for proton pump inhibitors (PPIs) is estimated at 30.0 billion won, compared with 23.0 billion a year ago.
Major items being offered on the domestic market last year were omeprazole prepa...
